Pharmafile Logo
Pharmafocus logo
Advanced Search

GSK

Showing 15 posts of 760 posts found.

GSK image

GSK/Prosensa confirm orphan drug setback

September 23, 2013
Sales and Marketing GSK, MD, Prosensa, drisapersen

An experimental treatment by GSK and Prosensa for a rare type of muscle-degenerating disease has failed to meet its primary …

News

GSK wins anthrax terrorism deal

September 20, 2013
Sales and Marketing GSK, anthrax, terrorism

News
gsk_hq_close

GSK’s Tafinlar/Mekinist combo given FDA priority review status

September 17, 2013
Research and Development, Sales and Marketing GSK, Roche, Tafinlar, Zelboraf, melanoma

News
gsk_hedge

GSK/Genmab leukaemia drug joins FDA speed lane

September 16, 2013
Research and Development, Sales and Marketing Arzerra, GSK, Genmab, Levact, MabThera, chronic lymphocytic leukaemia

News
Richard Bergström, EFPIA, all trials, ema

EFPIA slams EMA data proposals

September 10, 2013
Research and Development, Sales and Marketing AZ, EFPIA, EMA, GSK, Pfizer, Roche

The intense debate over how pharma should make trial data available has taken another turn as a major European industry …

News
GSK image

GSK completes £1.35 billion Suntory deal

September 10, 2013
Sales and Marketing GSK, Suntory, lucozade, ribena

GlaxoSmithKline has confirmed it is to sell Lucozade and Ribena to Japanese drinks giant Suntory Beverage & Food for £1.35 …

News
GSK china image

GSK has ‘serious concerns’ about China

September 9, 2013
Medical Communications, Sales and Marketing China, GSK, bribery

GlaxoSmithKline is said to be thinking about abandoning China altogether as the company continues to co-operate with the country’s authorities …

News
Manufacturing image

Manufacturing and production news in brief

September 6, 2013
Manufacturing and Production GSK, Jabones Pardo, Mylan, Shasun, Wockhardt

A round-up of pharma manufacturing facility news, with updates from Wockhardt, Mylan, GSK and Shasun, plus an FDA warning letter …

News
GSK lucozade image

GSK may sell Lucozade and Ribena to Japan’s Suntory

September 6, 2013
Sales and Marketing GSK, Suntory, lucozde, ribena

GSK is reportedly to sell its Lucozade and Ribena brands to Osaka-based Suntory in a deal worth up to £1.5 …

News
China image

China may be trying to ‘frighten’ pharma

September 6, 2013
Medical Communications, Sales and Marketing China, GSK, Sanofi, bribery

Western pharma companies caught up in Chinese probes over corruption are being discriminated against, according to a European business lobby …

News
GSK image

GSK cancer vaccine fails in Phase III

September 5, 2013
Research and Development, Sales and Marketing BMS, GSK, Yervoy, melanoma, phase III

GlaxoSmithKline’s hopes of creating a cancer vaccine against the deadliest form of skin cancer took a blow today when its …

News
GSK China image

GSK faces new China allegations

September 4, 2013
Medical Communications, Sales and Marketing China, GSK, bribery

GlaxoSmithKline is facing a potential worsening of its already embarrassing situation in China, where the UK-based group has been accused …

News
Tafinlar image

GSK’s skin cancer pill Tafinlar gets EMA approval

September 3, 2013
Sales and Marketing BMS, GSK, Tafinlar, Yervoy, melanoma

GSK has been granted EMA marketing authorisation for its new metastatic melanoma drug Tafinlar. The EMA’s decision on Tafinlar (dabrafenib) …

News
GSK image

GSK Crohn’s disease pill fails in Phase III

August 27, 2013
Sales and Marketing GSK, vercirnon

A late-stage trial of GlaxoSmithKline’s investigational Crohn’s disease drug failed to benefit patients. The SHIELD-1 study was investigating vercirnon – …

News
lilly_outside_plaque

Lilly drawn into China bribery scandal

August 22, 2013
Medical Communications, Sales and Marketing China, GSK, Sanofi, bribery, corruption, lilly, payments

News
The Gateway to Local Adoption Series

Latest content

STADA and Bio-Thera’s Gotenfia receives positive CHMP opinion for autoimmune diseases

December 18, 2025

Norgine enters exclusive licensing agreement with Vir Biotechnology

December 18, 2025

Incyclix appoints Kimberly Blackwell to Board of Directors

December 17, 2025

Hansa Biopharma appoints Max Sakajja as Vice President, General Manager Europe and International

December 17, 2025

GSK’s Exdensur receives MHRA approval for asthma and rhinosinusitis

December 16, 2025